Telephone and e-consultation are available when sought. Contact Us to arrange.
A comprehensive evaluation of the ocular surface, tear film, and meibomian glands is undertaken, including:
Symptom assessment & scoring
Standardised questionnaires such as SPEED and OSDI to quantify symptom severity and impact on quality of life
Blink rate and pattern analysis
Manual assessment to assess evaporative dry eye contribution
Tear film assessment
Tear osmolarity testing
Tear meniscus height / meniscometry (manual or OCT-based)
Meibomian gland evaluation
Manual gland expressibility and scoring
Ocular surface integrity
Corneal and conjunctival staining with fluorescein
Tear break-up time (TBUT) – invasive and non-invasive (NIBUT) using Placido-based videokeratography (Visionix)
Aqueous tear production
Schirmer’s testing
Comprehensive ocular examination
Lid position, lid margins, conjunctiva, cornea, and adnexal structures
Systemic assessment
Medical history and targeted investigations for contributing conditions such as rosacea, autoimmune disease (e.g. rheumatoid arthritis, Sjögren’s)
Inflammatory markers
Point-of-care testing for markers such as MMP-9 to assess ocular surface inflammation
Treatment is individualised based on dry eye subtype and severity and may include:
Lid-based therapies
Warm compresses (eye bags)
Lid hygiene (Blephaclean, blephawipes)
Lubrication
Preservative-free drops, gels, and ointments
Anti-inflammatory therapy
Short courses of topical steroids
Immunomodulators (e.g. ciclosporin)
Allergy and Demodex management
Tea tree oil–based regimens, lid margin care, epilation; selected cases may require ivermectin or pilocarpine
Advanced tear replacement
Autologous serum eye drops or autologous blood preparations
Tear conservation
Temporary or permanent punctum plugs
Systemic adjuncts
Omega-3 fatty acids
Doxycycline (for MGD / rosacea-associated disease)
Environmental and lifestyle measures
Humidifiers, screen-use modification
Multidisciplinary input
Immune work-up and co-management where indicated
Novel therapies
Tyrvaya® (varenicline) nasal spray for neuro-stimulatory tear production
For refractory or structurally driven disease:
Meibomian gland–targeted procedures
Mechanical gland expression
Meibomian gland probing
Tear drainage procedures (for watery eyes)
Punctal procedures
Dacryocystorhinostomy (DCR) where indicated
Advanced ocular surface rehabilitation
Trial of anaesthetic drops for diagnostic clarification
Scleral contact lenses to create a therapeutic tear chamber
Click here to see detailed price list for all consultations and procedures
We offer a comprehensive eye service delivered through specialist and generalist eye doctors.
Please click here to read on all our speciality procedures
Please note: Whilst these are the general suitability criteria, individual criteria has to be taken into account for specific patient needs and the appropriate procedure applicable.
We are not a cut-price service because quality does not come by making compromises. However we are competitive and transparent in our pricing structure. We make efforts to ensure that patients are made aware of all price points in advance of any consultations/investigations and procedures, to enable our patients to make an informed choice on how they would like to proceed. Read more on the details of our prices
We work with all insurers. Please refer to the above FAQ on “Pricing” for full details. Please note – even if your insurer is not on the list of companies provided, let us know and we can help to make arrangements. Read more on the insurers we work with – listed at the end of our Pricing section
As a general rule of thumb patients can expect a 95% chance of achieving functional vision to a high standard (corresponding to their best vision potential) from their initial surgery.
As with all forms of surgical treatments there are risks of unpredictable outcomes and complications. 1 to 5% of patients may have some difficulties but in the majority of cases these can be managed. The risk of severe and lasting problems is very low at 1:2500 or less per eye (so both eyes getting affected is very rare indeed).
You will of course be given a full explanation of the specific risks and benefits of the individual procedure applicable to you at the time of the consultation.
Eye doctors are at least five times more likely as the general public to choose vision correction surgery for themselves. The study, featured in the Journal of Cataract and Refractive Surgery, surveyed 250 surgeons who perform LASIK. Of those, 62.6 percent said they have already undergone LASIK to correct their vision, and 91 percent said they have done it or recommended it for their immediate family members.
Warrington
Wilmslow